FAKTOR OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000GH0DAD2

Real-time BOERSE MUENCHEN 11:25:45 18/07/2024 BST
1.533 EUR +1.12% Intraday chart for FAKTOR OPTIONSSCHEIN - ROCHE GS
Current month+29.35%
1 month+32.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
18/07/24 1.533 +1.12%
17/07/24 1.516 +17.70%
16/07/24 1.288 +2.06%
15/07/24 1.262 +2.77%
12/07/24 1.228 +4.16%

Real-time BOERSE MUENCHEN

Last update July 18, 2024 at 11:25 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Goldman Sachs
WKN GH0DAD
ISINDE000GH0DAD2
Date issued 21/01/2021
Strike 182.7 CHF
Maturity Unlimited
Parity 62.45 : 1
Emission price 2.99
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.9
Lowest since issue 0.749

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
274 CHF
Average target price
274 CHF
Spread / Average Target
0.00%
Consensus